Marshall Wace North America’s Twist Bioscience TWST Stock Holding History

Marshall Wace North America’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$45.9M	Buy	429,355 +68,994	+19%	+$7.9M	0.2%	108
2021 Q2	$48M	Buy	360,361 +70,166	+24%	+$8.16M	0.2%	108
2021 Q1	$35.9M	Sell	290,195 -318,333	-52%	-$48.3M	0.15%	163
2020 Q4	$86M	Buy	608,528 +311,033	+105%	+$34.5M	0.39%	51
2020 Q3	$22.6M	Sell	297,495 -30,748	-9%	-$1.91M	0.14%	176
2020 Q2	$14.9M	Buy	328,243 +305,210	+1,325%	+$11M	0.1%	215
2020 Q1	$704K	Buy	23,033 +12,790	+125%	+$344K	0.01%	690
2019 Q4	$215K	Buy	+10,243	New	+$240K	﹤0.01%	959

Other funds holding TWST

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Marshall Wace North America's TWST Position: Q3 2021 in Review

Marshall Wace North America increased its Twist Bioscience (TWST) stake by 19% in Q3 2021, buying an estimated $7.9M and bringing the position to 429,355 shares worth $45.9M. The position accounts for 0.2% of the portfolio, ranked #108.

Marshall Wace North America first reported a position in TWST in Q4 2019 and has held it in 8 quarters since. The position peaked at $86M in Q4 2020. 236 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

Marshall Wace North America held 429,355 shares of Twist Bioscience worth $45.9M as of Q3 2021.
Marshall Wace North America bought 68,994 Twist Bioscience shares in Q3 2021, an estimated $7.9M.
Twist Bioscience made up 0.2% of Marshall Wace North America's portfolio in Q3 2021, its #108 holding.
Marshall Wace North America first reported a position in Twist Bioscience in Q4 2019 and has held it in 8 quarters since.
Marshall Wace North America's Twist Bioscience position peaked at $86M in Q4 2020.
236 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.